Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed May 12, 2026 · 10-Q · 42 days after period end · 0001193125-26-218177
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$10.17M | -$12.83M | -$6.49M | -$8.99M |
| EPS Diluted | -$0.19 | -$0.37 | -$0.26 | -$0.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 12, 2026 · 42 d after period end
